Stock 300430 BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Beijing Chieftain Control Engineering Technology Co., Ltd.

Equities

300430

CNE100001YS5

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
18.6 CNY -5.92% Intraday chart for Beijing Chieftain Control Engineering Technology Co., Ltd. -1.69% +30.16%
28/04 Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/04 Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date 12 July 2023
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers.
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 July 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for 2021
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong signed a Letter of Intent to acquire a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers for approximately CNY 5.376 billion.
CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Tranche Update on Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2021.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300430 Stock
  4. News Beijing Chieftain Control Engineering Technology Co., Ltd.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW